Across TCGA pan-cancer cohorts, MIR200C RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR200C’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR200C RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR200C is over-expressed in tumor, although a few such as LUAD and THCA show the opposite, repressed pattern.

STAD, LUAD, and THCA are the cancer types where MIR200C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR200C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.276	.008	2	view →
LUAD	Female	All	−0.255	.009	2	view →
THCA	Female	III,IV	−0.708	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR200C RNA expression & survival · all MIR200C data types